Global and United States Over-The-Counter (OTC) Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 21-Sep-2020
No. of pages: 142
Inquire Before Buying

Over-The-Counter (OTC) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Over-The-Counter (OTC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Over-The-Counter (OTC) Drugs market is segmented into

- Cold and Flu Products

- Analgesics

- Dermatological Products

- Gastrointestinal Products

- Vitamin

- Other

Segment by Application, the Over-The-Counter (OTC) Drugs market is segmented into

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Regional and Country-level Analysis

The Over-The-Counter (OTC) Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Over-The-Counter (OTC) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Over-The-Counter (OTC) Drugs Market Share Analysis

Over-The-Counter (OTC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over-The-Counter (OTC) Drugs business, the date to enter into the Over-The-Counter (OTC) Drugs market, Over-The-Counter (OTC) Drugs product introduction, recent developments, etc.

The major vendors covered:

- Bayer

- Boehringer Ingelheim

- GSK

- Novartis

- Pfizer

- PGT healthcare

- Sanofi

- Teva Pharmaceuticals

- Takeda

- Cipla

- Sun Pharmaceutical Industries

- Glenmark

- Innovus Pharmaceuticals

Global and United States Over-The-Counter (OTC) Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Over-The-Counter (OTC) Drugs Product Introduction
1.2 Market Segments
1.3 Key Over-The-Counter (OTC) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type
1.4.2 Cold and Flu Products
1.4.3 Analgesics
1.4.4 Dermatological Products
1.4.5 Gastrointestinal Products
1.4.6 Vitamin
1.4.7 Other
1.5 Market by Application
1.5.1 Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over-The-Counter (OTC) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Over-The-Counter (OTC) Drugs Revenue 2015-2026
2.1.2 Global Over-The-Counter (OTC) Drugs Sales 2015-2026
2.2 Global Over-The-Counter (OTC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Over-The-Counter (OTC) Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Region (2021-2026)
3 Global Over-The-Counter (OTC) Drugs Competitor Landscape by Players
3.1 Global Top Over-The-Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Global Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Over-The-Counter (OTC) Drugs Manufacturers by Revenue
3.2.1 Global Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over-The-Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over-The-Counter (OTC) Drugs Revenue in 2019
3.2.5 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Over-The-Counter (OTC) Drugs Price by Manufacturers
3.4 Global Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over-The-Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over-The-Counter (OTC) Drugs Market Size by Type (2015-2020)
4.1.1 Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020)
4.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020)
4.1.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over-The-Counter (OTC) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Over-The-Counter (OTC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over-The-Counter (OTC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over-The-Counter (OTC) Drugs Market Size by Application (2015-2020)
5.1.1 Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020)
5.1.2 Global Over-The-Counter (OTC) Drugs Revenue by Application (2015-2020)
5.1.3 Over-The-Counter (OTC) Drugs Price by Application (2015-2020)
5.2 Over-The-Counter (OTC) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Over-The-Counter (OTC) Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Over-The-Counter (OTC) Drugs Sales YoY Growth 2015-2026
6.1.2 United States Over-The-Counter (OTC) Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Over-The-Counter (OTC) Drugs Market Share in Global Market 2015-2026
6.2 United States Over-The-Counter (OTC) Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Over-The-Counter (OTC) Drugs Players by Sales (2015-2020)
6.2.2 United States Top Over-The-Counter (OTC) Drugs Players by Revenue (2015-2020)
6.3 United States Over-The-Counter (OTC) Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Over-The-Counter (OTC) Drugs Price by Type (2015-2020)
6.4 United States Over-The-Counter (OTC) Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Over-The-Counter (OTC) Drugs Price Forecast by Type (2021-2026)
6.5 United States Over-The-Counter (OTC) Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Over-The-Counter (OTC) Drugs Price by Application (2015-2020)
6.6 United States Over-The-Counter (OTC) Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Over-The-Counter (OTC) Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
7.2 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
7.2.1 North America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020)
7.2.2 North America Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
8.2 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
8.2.1 Europe Over-The-Counter (OTC) Drugs Sales by Country
8.2.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
10.2.1 Latin America Over-The-Counter (OTC) Drugs Sales by Country
10.2.2 Latin America Over-The-Counter (OTC) Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Over-The-Counter (OTC) Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country
11.2.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
12.1.5 Bayer Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Corporation Information
12.2.2 Boehringer Ingelheim Description and Business Overview
12.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Over-The-Counter (OTC) Drugs Products Offered
12.3.5 GSK Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Over-The-Counter (OTC) Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Over-The-Counter (OTC) Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 PGT healthcare
12.6.1 PGT healthcare Corporation Information
12.6.2 PGT healthcare Description and Business Overview
12.6.3 PGT healthcare Sales, Revenue and Gross Margin (2015-2020)
12.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Products Offered
12.6.5 PGT healthcare Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Over-The-Counter (OTC) Drugs Products Offered
12.7.5 Sanofi Recent Development
12.8 Teva Pharmaceuticals
12.8.1 Teva Pharmaceuticals Corporation Information
12.8.2 Teva Pharmaceuticals Description and Business Overview
12.8.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Products Offered
12.8.5 Teva Pharmaceuticals Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Description and Business Overview
12.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Over-The-Counter (OTC) Drugs Products Offered
12.9.5 Takeda Recent Development
12.10 Cipla
12.10.1 Cipla Corporation Information
12.10.2 Cipla Description and Business Overview
12.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Cipla Over-The-Counter (OTC) Drugs Products Offered
12.10.5 Cipla Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer Over-The-Counter (OTC) Drugs Products Offered
12.11.5 Bayer Recent Development
12.12 Glenmark
12.12.1 Glenmark Corporation Information
12.12.2 Glenmark Description and Business Overview
12.12.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Glenmark Products Offered
12.12.5 Glenmark Recent Development
12.13 Innovus Pharmaceuticals
12.13.1 Innovus Pharmaceuticals Corporation Information
12.13.2 Innovus Pharmaceuticals Description and Business Overview
12.13.3 Innovus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Innovus Pharmaceuticals Products Offered
12.13.5 Innovus Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Over-The-Counter (OTC) Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over-The-Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Over-The-Counter (OTC) Drugs Market Segments
Table 2. Ranking of Global Top Over-The-Counter (OTC) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Cold and Flu Products
Table 5. Major Manufacturers of Analgesics
Table 6. Major Manufacturers of Dermatological Products
Table 7. Major Manufacturers of Gastrointestinal Products
Table 8. Major Manufacturers of Vitamin
Table 9. Major Manufacturers of Other
Table 10. Global Over-The-Counter (OTC) Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Over-The-Counter (OTC) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Over-The-Counter (OTC) Drugs Sales by Regions 2015-2020 (K Units)
Table 13. Global Over-The-Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Over-The-Counter (OTC) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Over-The-Counter (OTC) Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 16. Global Over-The-Counter (OTC) Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Over-The-Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2019)
Table 20. Over-The-Counter (OTC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Over-The-Counter (OTC) Drugs Price (2015-2020) (USD/Unit)
Table 23. Over-The-Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Over-The-Counter (OTC) Drugs Product Type
Table 25. Date of International Manufacturers Enter into Over-The-Counter (OTC) Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 28. Global Over-The-Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 29. Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Over-The-Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 31. Over-The-Counter (OTC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Over-The-Counter (OTC) Drugs Sales Share by Type (2021-2026)
Table 33. Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Over-The-Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 35. Global Over-The-Counter (OTC) Drugs Sales Share by Application (2021-2026)
Table 36. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Over-The-Counter (OTC) Drugs Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States Over-The-Counter (OTC) Drugs Sales (K Units) of Key Companies (2015-2020)
Table 40. United States Over-The-Counter (OTC) Drugs Sales Share by Company (2015-2020)
Table 41. United States Over-The-Counter (OTC) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 42. United States Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2015-2020)
Table 43. United States Over-The-Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 44. United States Over-The-Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States Over-The-Counter (OTC) Drugs Price (K Units) by Type (2015-2020)
Table 46. United States Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2021-2026)
Table 47. United States Over-The-Counter (OTC) Drugs Sales Share by Type (2021-2026)
Table 48. United States Over-The-Counter (OTC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States Over-The-Counter (OTC) Drugs Revenue Share by Type (2021-2026)
Table 50. United States Over-The-Counter (OTC) Drugs Price (K Units) by Type (2021-2026)
Table 51. United States Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2015-2020)
Table 52. United States Over-The-Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 53. United States Over-The-Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2021-2026)
Table 55. United States Over-The-Counter (OTC) Drugs Sales Share by Application (2021-2026)
Table 56. United States Over-The-Counter (OTC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States Over-The-Counter (OTC) Drugs Revenue Share by Application (2021-2026)
Table 58. North America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 59. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 60. North America Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 62. Europe Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 63. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 64. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region (2015-2020) (K Units)
Table 67. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Table 70. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 71. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2015-2020) (K Units)
Table 75. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2015-2020)
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Bayer Over-The-Counter (OTC) Drugs Product
Table 82. Bayer Recent Development
Table 83. Boehringer Ingelheim Corporation Information
Table 84. Boehringer Ingelheim Description and Business Overview
Table 85. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Boehringer Ingelheim Product
Table 87. Boehringer Ingelheim Recent Development
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. GSK Product
Table 92. GSK Recent Development
Table 93. Novartis Corporation Information
Table 94. Novartis Description and Business Overview
Table 95. Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Novartis Product
Table 97. Novartis Recent Development
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Pfizer Product
Table 102. Pfizer Recent Development
Table 103. PGT healthcare Corporation Information
Table 104. PGT healthcare Description and Business Overview
Table 105. PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. PGT healthcare Product
Table 107. PGT healthcare Recent Development
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Business Overview
Table 110. Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Sanofi Product
Table 112. Sanofi Recent Development
Table 113. Teva Pharmaceuticals Corporation Information
Table 114. Teva Pharmaceuticals Description and Business Overview
Table 115. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Teva Pharmaceuticals Product
Table 117. Teva Pharmaceuticals Recent Development
Table 118. Takeda Corporation Information
Table 119. Takeda Description and Business Overview
Table 120. Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Takeda Product
Table 122. Takeda Recent Development
Table 123. Cipla Corporation Information
Table 124. Cipla Description and Business Overview
Table 125. Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Cipla Product
Table 127. Cipla Recent Development
Table 128. Sun Pharmaceutical Industries Corporation Information
Table 129. Sun Pharmaceutical Industries Description and Business Overview
Table 130. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Sun Pharmaceutical Industries Product
Table 132. Sun Pharmaceutical Industries Recent Development
Table 133. Glenmark Corporation Information
Table 134. Glenmark Description and Business Overview
Table 135. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Glenmark Product
Table 137. Glenmark Recent Development
Table 138. Innovus Pharmaceuticals Corporation Information
Table 139. Innovus Pharmaceuticals Description and Business Overview
Table 140. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Innovus Pharmaceuticals Product
Table 142. Innovus Pharmaceuticals Recent Development
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Over-The-Counter (OTC) Drugs Players
Table 147. Over-The-Counter (OTC) Drugs Customers List
Table 148. Over-The-Counter (OTC) Drugs Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Over-The-Counter (OTC) Drugs Product Picture
Figure 2. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Cold and Flu Products Product Picture
Figure 4. Analgesics Product Picture
Figure 5. Dermatological Products Product Picture
Figure 6. Gastrointestinal Products Product Picture
Figure 7. Vitamin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Over-The-Counter (OTC) Drugs Report Years Considered
Figure 14. Global Over-The-Counter (OTC) Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Over-The-Counter (OTC) Drugs Sales 2015-2026 (K Units)
Figure 16. Global Over-The-Counter (OTC) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 19. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 21. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Over-The-Counter (OTC) Drugs Revenue in 2019
Figure 23. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2019
Figure 26. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type in 2019
Figure 28. Global Over-The-Counter (OTC) Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2019
Figure 31. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application in 2019
Figure 33. United States Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 34. United States Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States Over-The-Counter (OTC) Drugs Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest Over-The-Counter (OTC) Drugs Players Market Share by Revenue in Over-The-Counter (OTC) Drugs in 2019
Figure 37. United States Over-The-Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Figure 38. United States Over-The-Counter (OTC) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States Over-The-Counter (OTC) Drugs Revenue Share by Application (2015-2020)
Figure 40. United States Over-The-Counter (OTC) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 44. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 45. U.S. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country in 2019
Figure 52. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country in 2019
Figure 53. Germany Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. France Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. U.K. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Italy Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Russia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Over-The-Counter (OTC) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 64. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2019
Figure 66. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2019
Figure 67. China Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. China Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Japan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. South Korea Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. India Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Australia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Taiwan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Indonesia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Thailand Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Malaysia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Over-The-Counter (OTC) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Philippines Over-The-Counter (OTC) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs